Altre lingue Emergent BioSolutions Inc.

Azioni

EBS

US29089Q1058

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 26/04/2024			Variaz. 5gg	Var. 1 gen.
1,92 ^USD	-1,54%		-5,88%	-20,00%

24/04	Amneal Pharmaceuticals ha ottenuto l'autorizzazione dalla FDA a vendere la versione generica dello spray nasale per il trattamento dell'overdose da oppioidi -- Azioni in rialzo	MT
25/03	Emergent ottiene dalla FDA lo stato di 'Nessuna Azione Indicata' per l'impianto di produzione di Baltimore Bayview	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	24/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results and Conduct Conference Call on May 1, 2024	23/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024	22/04
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis	28/03
Emergent Gets FDA's 'No Action Indicated' Status For Baltimore Bayview Manufacturing Facility	25/03
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Emergent Biosolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Sector Update: Health Care Stocks Rise Late Afternoon	12/03
Sector Update: Health Care Stocks Higher in Afternoon Trading	12/03
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade	12/03
Emergent BioSolutions Shares Drop on S&P Downgrade	12/03
North American Morning Briefing : Stock Futures -2-	08/03
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 7 PM ET	07/03
Emergent Biosolutions: Q4 Earnings Snapshot	06/03
(EBS) EMERGENT BIOSOLUTIONS Sees Q1 Revenue Range $200M - $250M	06/03
Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q4 Revenue $277M, vs. Street Est of $274M	06/03
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results	06/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Emergent BioSolutions Inc.

Azioni

EBS

US29089Q1058

Altre lingue

Filtri